Cardiovascular drug therapy and surrogate COVID-19 outcomes: which is the impact of the “miraculous” sodium-glucose co-transporter-2 inhibitors? Author’s reply

Polish Heart Journal (Kardiologia Polska)
Vol 79, No 9 (2021) Cardiovascular drug therapy and surrogate COVID-19 outcomes: which is the impact of the “miraculous” sodium-glucose co-transporter-2 inhibitors? Author’s reply

Vol 79, No 9 (2021)

Letter to the Editor

Published online: 2021-07-22

Page views 730

Article views/downloads 605

Get Citation

Connect on Social Media

Michał Terlecki¹, Wiktoria Wojciechowska¹, Marek Klocek¹, Michał Kania², Maciej Małecki², Tomasz Grodzicki³, Marek Rajzer¹

DOI: 10.33963/KP.a2021.0071

Pubmed: 34292566

Kardiol Pol 2021;79(9):1050-1051.

Not available

About Via Medica Advertising

Bookstore (Ikamed) TVMed

News